News
Trane Technologies Schedules Fourth Quarter 2021 Earnings Conference Call
Trane Technologies plc (NYSE:TT), a global climate innovator, will host a conference call to discuss its fourth quarter 2021 financial results on Monday, January 31, 2022, at 10 a.m. ET. The
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the
EQS-News: Nordea Bank Abp: Transaction in Own Shares
Quidel to Present at 40th Annual J.P. Morgan Healthcare Conference
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the 40th
State Street Corporation Announces Date for Release of Fourth-Quarter and Full-Year 2021 Financial Results and Conference Call Webcast
State Street Corporation (NYSE: STT) plans to announce its fourth-quarter and full-year 2021 financial results on Wednesday, January 19, 2022 at approximately 7:30 a.m. ET. The results will be
Pfizer to Provide U.S. Government with an Additional 10 Million Treatment Courses of its Oral Therapy to Help Combat COVID-19
Pfizer Inc. (NYSE: PFE) announced that the U.S. government has committed to purchasing an additional 10 million treatment courses of its COVID-19 oral therapy, PAXLOVID™ (nirmatrelvir [PF-07321332]
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and CEO, at the 40th Annual J.P. Morgan Healthcare Conference on
Advisory: Chevron Corporation’s 4Q 2021 Earnings Conference Call and Webcast
Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its quarterly earnings conference call on Friday, January 28, 2022, at 11:00 a.m. ET (8:00 a.m. PT).
Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference
DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer, Chairman, President and Chief Executive Officer, will present an update on the company at the 40th annual J.P. Morgan Healthcare
EQS-News: Nordea Bank Abp: Flagging notification
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
DGAP-Adhoc: BASF SE: BASF beschließt Aktienrückkaufprogramm mit einem Volumen von bis zu 3 Milliarden €
DGAP-Adhoc: BASF SE: BASF resolves on share buyback program with a volume of up to €3 billion
Neuer Rekord an der Wall Street: Apple erreicht als erstes Unternehmen einen Börsenwert von drei Billionen Dollar
EQS-News: Holcim completes acquisition in the US Pacific Northwest region
Verisign to Report Fourth Quarter and Full Year 2021 Financial Results
VeriSign, Inc. (NASDAQ: VRSN), a global provider of domain name registry services and internet infrastructure, today announced that its earnings call for the fourth quarter and full year 2021, will
IFF and SleepScore Labs to Unveil Validated Scent Solutions to Support Improved Sleep at CES 2022
IFF (NYSE: IFF) and SleepScore Labs introduce a groundbreaking scent solution to improve sleep quality, building on the partnership initiated in 2020 and leveraging IFF’s internal Science of
Vancouver Clinic and Humana Introduce New Primary Care Practice Designed to Enhance Medicare Advantage Experience
Vancouver Clinic and Humana have teamed up to bring additional access to patient-focused primary care to Gresham, Oregon. Enliven by Vancouver Clinic (Enliven) recently opened its doors for the
Exelon to Host Investor and Analyst Events for Exelon and Constellation to Discuss Post-Separation Strategies
Exelon Corp. (Nasdaq: EXC) today announced that it will host virtual investor and analyst events to highlight the post-separation business strategies for Exelon and Constellation.
Exelon’s event
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) of a booster dose of the
Marsh McLennan to Host Fourth Quarter Earnings Investor Call on January 27
Marsh McLennan (NYSE: MMC), the world’s leading professional services firm in the areas of risk, strategy and people, plans to announce fourth quarter financial results via news release on